By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aquinox Pharmaceuticals 

5600 Parkwood Way
Suite 430
Richmond  British Columbia  V6V 2M2  U.S.A.
Phone: 604-629-9223 Fax: 604-295-4748




Company News
Aquinox (AQXP) Announces Positive Results From Secondary Endpoints From Phase II LEADERSHIP Trial In BPS/IC And Reports Second Quarter 2015 Financial Results 8/6/2015 3:06:01 PM
Aquinox (AQXP) To Present At The Canaccord Genuity 35th Annual Growth Conference 8/5/2015 11:08:08 AM
Aquinox (AQXP) Announces Results From FLAGSHIP Trial With AQX-1125 In Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations 7/9/2015 7:20:32 AM
Aquinox (AQXP)’s Bladder Pain Drug Fails to Meet Statistical Endpoint in Phase II Trial 6/25/2015 7:29:05 AM
Aquinox Pharmaceuticals (AQXP) To Present At 2015 Jefferies and Co. Global Healthcare Conference 5/26/2015 8:06:45 AM
Aquinox Pharmaceuticals (AQXP) Announces First Quarter 2015 Financial Results 5/12/2015 8:24:53 AM
Aquinox Pharmaceuticals (AQXP) Completes Enrollment In The Phase II KINSHIP Trial Of AQX-1125 In Atopic Dermatitis 5/4/2015 7:34:03 AM
Aquinox Pharmaceuticals (AQXP) To Present At 2015 Bloom Burton & Co. Healthcare Investor Conference 4/27/2015 10:11:56 AM
Aquinox Pharmaceuticals (AQXP) To Present At 14th Annual Needham Healthcare Conference 4/7/2015 7:53:03 AM
Aquinox Pharmaceuticals (AQXP) Announces Year End 2014 Financial Results 3/17/2015 7:38:54 AM